- Panomics, Inc. to be Acquired by Affymetrix - November 11, 2008
- VIA Pharmaceuticals Announces Positive P2 Results in VIA-2291 Studies - November 9, 2008
- PTC Therapeutics PTC 124 Study Shows Improvements in CF Patients - October 24, 2008
- Phenomix and Forest Laboratories to Collaborate on Dutogliptin in Diabetes - October 23, 2008
- Poniard Announces Positive Incremental Data in Prostate Cancer Trial - October 22, 2008
- Poniard Announces Positive P2 Trial Data in Patients with Colorectal Cancer - October 22, 2008
- Poniard's Picoplatin Named Among Top 10 Most Promising Oncology Products - October 21, 2008
- ProGenTech Signs Licensing Agreement with Human Genetic Signatures - October 7, 2008
- EnteroMedics Presents VBLOC(TM) Therapy Data at IFSO World Congress - September 26, 2008
- Ingenuity Systems Announces Deal with Bristol-Myers Squibb for IPA - September 2, 2008
- Cadence Pharmaceuticals Announces FDA Concurrence for Acetavance Plan - July 30, 2008
- PTC Therapeutics to Collaborate with Genzyme on PTC124 - July 17, 2008
- PTC Therapeutics Announces $25M Award From Cystic Fibrosis Foundation - July 16, 2008
- Epocrates Drug and Formulary Application on Apple App Store - July 14, 2008
- VIA Pharmaceuticals Set to Join Russell Microcap Index - June 27, 2008
- Calypso® Medical’s Eric R. Meier Named Ernst & Young Entrepreneur Of The Year® - June 20, 2008
- PTC Therapeutics Announces Data From Additional Clinical Studies of PTC124 - June 12, 2008
- Protez Pharmaceuticals to be Acquired by Novartis - June 04, 2008
- IDev Technologies Announces Distribution Partnership with YMed - June 4, 2008
- BioSeek to Collaborate with Merck Serono to Assess Potential Drug Candidates - May 20, 2008
- BioSeek Initiates Research Collaboration with Lexicon Pharmaceuticals - April 29, 2008
- PTC Therapeutics Announces Initiation of Clinical Trial of PTC124 - April 23, 2008
- BrainCells Inc. Initiates P2 Clinical Trial with BCI-540 for Depression with Anxiety - April 17, 2008
- BrainCells Inc. Expands Series B Financing to $50 Million - April 17, 2008
- ProGenTech Completes $21 Million Series C Financing - April 2, 2008
- Metabolex Initiates Phase I Trial of MBX-2982 - March 26, 2008
- Ingenuity Systems Delivers Key Milestones in FDA Collaboration - March 25, 2008
- Presidio Pharmaceuticals Gets Exclusive Rights to XTL's HCV NS5A Program - March 20, 2008
- VIA Pharmaceuticals Completes Enrollment in P2 VIA-2291 Trials - March 20, 2008
- BrainCells Completes $30M Initial Closing of Series B Financing - March 10, 2008
- Cadence Pharmaceuticals Completes $49.3M Registered Direct Offering - February 20, 2008
- Perlegen and SCLRC to Collaborate on Interferon Response Studies - Februrary 19, 2008
- Poniard Announces Positive Results in Prostate Cancer Study - February 15, 2008
- Presidio Pharmaceuticals and Numerate Announce Research Collaboration - February 11, 2008
- Poniard Appoints Robert De Jager, MD, as Chief Medical Officer - February 4, 2008
- Phenomix Files Registration Statement for Proposed IPO - January 25, 2008
- MAP Pharmaceuticals Reaches Agreement with FDA for MAP0004 Trial - January 16, 2008
- EnteroMedics™ Announces 9-Month Results on VBLOC-RF2 Study - January 8, 2008
- MAP Pharmaceuticals Initiates Phase 3 Trial of Unit Dose Budesonide - January 7, 2008
- Epocrates Annouces Strategic Investment by Goldman Sachs - January 7, 2008
- EnteroMedics™ Announces Pivotal EMPOWER Study - January 7, 2008
- Aragon Surgical Secures $25 Million in Series B Financing - January 7, 2008
